Journal of Psychoactive Drugs

Papers
(The TQCC of Journal of Psychoactive Drugs is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
A Dose of Creativity: An Integrative Review of the Effects of Serotonergic Psychedelics on Creativity62
Anxiety-related Symptoms following the Sporadic Use of Ecstasy – A Case Study42
“Pressed OXY M30 Pills, Great Press, Potent, Fast Shipping!!!”: Availability of Counterfeit and Pharmaceutical Oxycodone Pills on One Major Cryptomarket40
Methamphetamine-Induced Wakefulness and Sleep Management: A Qualitative Analysis of Online Narratives27
Factors Associated with an Increased Risk of Opioid Misuse Among Patients with Non-Cancer Pain in Malaysian Pain Clinic Settings27
Prevalence and Correlates of Lifetime Ecstasy/MDMA Use Among Asian American and Pacific Islander Adult Populations in the United States, 2015–202025
Vermont Primary Care Provider Perspectives on Psychedelics — A Cross-Sectional Study23
The Differential Contribution of Adverse Childhood Experiences and Perceived Discrimination on Substance Use among Hispanic Emerging Adults18
Clinical Characteristics of Health Professions Students with Nitrous Oxide Use Disorder16
Substance use Attitudes, Beliefs, Experience, and Knowledge Among Nursing and Nursing Assistant Students16
“Getting to the Root”: Ayahuasca Ceremony Leaders’ Perspectives on Eating Disorders15
Prevalence and Predictors of Psychoactive Drug Use among Chinese Men Who Have Sex with Men: A Longitudinal and Mediation Study15
Acculturation Style Is Associated with Stress and Tobacco Use among East African Immigrants15
Predictors of Psychedelic Experience: A Thematic Analysis14
A Nationwide Study Comparing Mental Health Professionals’ Willingness to Try Hallucinogenic Drugs in Basic Research or Clinical Practice14
Mixed-Methods Study of Use and Attitudes About Psychedelics for Therapeutic Purposes Among Low-Income U.S. Veterans Nationally12
Psychedelic Science, Contemplative Practices, and Indigenous and Other Traditional Knowledge Systems: Towards Integrative Community-Based Approaches in Global Health12
Effects of Cannabis Use on Neurocognition: A Scoping Review of MRI Studies10
Cannabis for Healing in a Native Community Clinic: Development and Results from an Informatics Research Tool10
Youth and Young Adults’ Knowledge and Perceptions of Risks and Benefits Regarding Cannabis Products: A Cross-Sectional Analysis of Over 1,700 Individuals9
Exploring Cultural Competence, Inclusivity, and Diversity in Ketamine Assisted Psychotherapy: A Phenomenological Study9
Risk for Ecstasy Use Disorder and Other Substance Use Among International Users of Recreational Ecstasy/Molly/MDMA9
Sleep-Related Cannabis Expectancy Questionnaire (SR-CEQ): Factor Analysis Replication, Internal Reliability, and Construct Validity9
Caregivers’ Attitudes Toward Treatment Length for Persons in Swedish Opioid Agonist Treatment. A Qualitative Interview Study9
Health-Promoting Behaviors in Male Patients with Opioid Use Disorder: An Exploratory Study8
Exploring the Use of Psilocybin Therapy for Existential Distress: A Qualitative Study of Palliative Care Provider Perceptions8
Examining Predictors of Nicotine Dependence in Korean Adolescents : Comparing Ever Quitters and Never Quitters8
Lived Experiences of Nonmedical Use of Tramadol Among Urban Slum-Dwelling Youth in Ghana: A Qualitative Study8
Prevalence and Patterns of Cannabis Product Adulteration: An Analysis of WEDINOS Data8
Exposure to Secondhand Smoke at Home and Psychological Distress among College Students in China: The Role of Parental Attachment8
Decisional Balance of Smoking and Planning to Quit Smoking: A Moderated Mediation Model among Chinese Male Smokers7
Sex Moderates Associations Between Dimensions of Emotion Dysregulation and Problematic Cannabis Use7
Assessing Technical Assistance Needs among Recovery Residence Operators in the United States7
Prevalence and Correlates of GHB Use among Adults in the United States7
Psychedelic Experiences and Mindfulness are Associated with Improved Wellbeing7
Ayahuasca Ritual, Personality and Sociality: Observational Research Conducted in a Substance Use Disorder Rehabilitation Center in Uruguay7
Co-use of Tobacco Products and Cannabis among Veterans: A Preliminary Investigation of Prevalence and Associations with Mental Health Outcomes7
Smoking Outcome Expectancies in Chinese Young Adults7
The Pharmacokinetics of Ketamine in the Breast Milk of Lactating Women: Quantification of Ketamine and Metabolites7
Mystical and Affective Aspects of Psychedelic Use in a Naturalistic Setting: A Linguistic Analysis of Online Experience Reports6
Positive and Negative Pathways Linking Depressive Symptoms to Problematic Alcohol Use Among Argentinian College Students: An Examination of Positive and Negative Urgency Traits and Internal Drinking M6
Indigenous Voices in Psychedelic Therapy: Experiential Learnings from a Community-Based Group Psychedelic Therapy Program6
Impact of a Naturalistic Psychedelic Experience on Smoking: A Retrospective Survey6
The Role of Savoring in Young Adult Cannabis Use and Associated Consequences: A Replication Study6
Attitudes Toward the Use of Medical Cannabis and the Perceived Efficacy, Side-effects and Risks: A Survey of Patients, Nurses and Physicians6
Therapeutic Protocols Using Ketamine and Esketamine for Depressive Disorders: A Systematic Review6
Safety and Efficacy of Ashwagandha Root Extract on Cognition, Energy and Mood Problems in Adults: Prospective, Randomized, Placebo-Controlled Study5
Ketamine-Assisted Psychotherapy for Antisocial Personality Disorder: A Case Report5
Three Cases of Reported Improvement in Microsmia and Anosmia Following Naturalistic Use of Psilocybin and LSD5
Bibliometric Analysis of Academic Journal Articles Reporting Results of Psychedelic Clinical Studies5
Psychedelic Experiences Increase Mind Perception but do not Change Atheist-Believer Status: A Prospective Longitudinal Study5
Therapeutic Potential of Psilocybin for Treating Neuropsychiatric Long COVID Symptoms: A Reddit Investigation5
Maintenance Intramuscular Ketamine-Assisted Psychotherapy, a Retrospective Chart Review of Efficacy, Adverse Events, and Dropouts from a Community Practice5
Multidimensional Acculturation, Acculturative Stress and Alcohol or Drug Use of Adult Latinx Immigrants5
Negative Affect Regulation and Marijuana Use in College Students: Evaluating the Mediating Roles of Coping and Sleep Motives5
Efficacy and Safety of Four Psychedelic-Assisted Therapies for Adults with Symptoms of Depression, Anxiety, and Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis5
Factors Associated with Psychosis in 2098 Methamphetamine Users Admitted to 104 Outpatient Counseling Centers in 80 Cities in Turkey5
How Important Is a Guide Who Has Taken Psilocybin in Psilocybin-Assisted Therapy for Depression?5
Healing Words: Effects of Psychoeducation on Likelihood to Seek and Refer Psychedelic-Assisted Psychotherapy Among BIPOC Individuals4
Religion, Psychedelics, Risky Behavior, and Violence4
Acute Psychedelic Reactions, Post-Acute Changes in Dysfunctional Attitudes, and Psychedelic-Associated Changes in Wellbeing4
Biennial Changes in the Characteristics of Patients with Methamphetamine Use Disorder in Japan from 2000 to 20204
Effects of Ayahuasca on Gratitude and Relationships with Nature: A Prospective, Naturalistic Study4
Associations of Lifetime Nonmedical Opioid, Methamphetamine, and Kratom Use within a Nationally Representative US Sample4
Characteristics of Cannabis and Opioid Users Among Older U.S. Veterans and Their Health Outcomes: A Longitudinal Perspective4
The Healthcare Profession as a Determinant of Depression, Suicidal Ideation, and Drug Use in Spain During the COVID-19 Pandemic Crisis4
Predictors of Five-year Readmission to an Inpatient Service among Patients with Opioid Use Disorders4
Fear of COVID-19 Diagnosis and Cannabis Use Patterns Among Adults with Chronic Health Conditions: Results from COVID-19 Cannabis Health Study4
Cannabis Consumption Onset and Addiction: Data from the Second Brazilian Drugs and Alcohol Survey (BNADS)4
Survey of U.S. Residents and Their Usage of Electronic Cigarettes with Drugs Other Than Nicotine4
The Use of Psilocybin in the Treatment of Psychiatric Disorders with Attention to Relative Safety Profile: A Systematic Review4
Inhaled Dimethyltryptamine (DMT): Use Patterns and Predictors of Consumption Frequency4
Patterns of Opioid and NSAID Use in Saudi Arabia from 2010 to 20204
Does the Perception of Risk Associated with Psychedelics Use Differ in Physicians According to Their Belief of Effectiveness?4
On the mushrooming reports of “quiet quitting”: Employees’ lifetime psilocybin use predicts their overtime hours worked4
Efficacy of Extended-Release Injectable Naltrexone on Alcohol Use Disorder Treatment: A Systematic Review4
Differences in Online Descriptions and Marketing of Derived Intoxicating Cannabis Products4
Opioid Use Disorder and COVID-19: Treatment and Recovery Factors among Vulnerable Populations at the Intersection of Two U.S. Epidemics4
A Qualitative Inquiry into the Challenges in Overcoming Heroin Addiction Among Chinese Individuals Who Experience Voluntary Rehabilitation3
Drug use Risks in Portuguese Rural vs Urban Environments: Harm Reduction Challenges in a Progressive Drug Policy Setting3
An Assessment of Psychedelic Knowledge Among People Using Psychedelics Naturalistically3
Direct-To-Definitive Urine and Oral Fluid Test Results for Unscreened and Rarely Screened Drugs in Individuals Applying for Methadone Treatment in 7 U.S. States3
The Epidemiology of Psychedelic Use Among United States Military Veterans3
Therapeutic Use and Other Reasons to Consume Cannabidiol: Insight from the French and Italian Contexts3
The Role of Gabapentinoids in the Substance Use Pattern of Adult Germans Seeking Inpatient Detoxification Treatment – A Pilot Study3
Childhood Religious Affiliation Type Is Associated with Alcohol, but Not Cannabis Use in Adults3
Cognitive Behavioral Therapy, Ketamine, and Combination Treatment for Depression: Impressions of Credibility in Participants with Self-Reported Depressive Symptoms3
Menstrual Changes and Reversal of Amenorrhea Induced by Classic Psychedelics: A Case Series3
Health Benefits and Positive Acute Effects of Psilocybin Consumption: A Quantitative Textual Analysis of User Self-Reported Data3
Exploring the Role of Traumatic Event Exposure in Tobacco Dependence Treatment Outcomes Among African Americans3
Kratom Retail Availability in Fort Worth, Texas3
Prevalence and Use Patterns of Kratom ( Mitragyna speciosa Korth.) in a US Nationally Representative Sample3
Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders3
Ethical Issues in Treating Substance Use Disorders: Counselor Perspectives3
Psychedelic Experiences After Bereavement Improve Symptoms of Grief: The Influence of Emotional Breakthroughs and Challenging Experiences3
Gender Differences in the Relationship between Methamphetamine Use and High-risk Sexual Behavior among Prisoners: A Nationwide, Cross-sectional Survey in Japan3
Seasonal Variation of Use of Common Psychedelics and Party Drugs Among Nightclub/Festival Attendees in New York City3
A Meta-Analysis of Functional Neuroimaging Studies of Ketamine Administration in Healthy Volunteers3
The Index of Cannabis Equivalence (ICE): A User-Centered Approach to Standardization of Cannabis Dose–Response3
Polydrug Use and Co-occurring Substance Use Disorders in a Respondent Driven Sampling of Cocaine Base Paste Users in Santiago, Chile3
Depression and Substance Use Among Brazilian University Students During the COVID-19 Pandemic3
0.26462006568909